Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for

We identified a total of 14 studies with a low or medium risk of bias for use in our main network meta-analyses (NWMA) comparing the efficacy of drug therapies for early rheumatoid arthritis. Those findings are presented in our main report.

MetaInsight: An interactive web‐based tool for analyzing, interrogating, and visualizing network meta‐analyses using R‐shiny and netmeta - Owen - 2019 - Research Synthesis Methods - Wiley Online Library

Meta-analysis and the science of research synthesis

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

Chapter 10: Analysing data and undertaking meta-analyses

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

Frontiers Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis

Mapping the characteristics of network meta-analyses on drug therapy: A systematic review